Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently ...

The proposed Coordinate-Aware Feature Excitation (CAFE) module and Position-Aware Upsampling (Pos-Up) module both adhere to ...

The challenge for British security leaders is no longer whether NCSC guidance on credential management is sound, but how to ...

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...

Compute remains essential, but the ability to translate that compute into reliable, repeatable outcomes is where competitive ...

Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

Companies investing in unified, managed and rich data layers will drive innovation in the coming decade. Through these ...

Across much of the world, a tiny striped insect shapes whether families stay healthy or get sick. The Asian tiger mosquito ...

LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...